Old names:
Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Instadose Pharma Corp.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0001477932-23-006966 (34 Act) Size: 134 KB |
Sep-19-2023 | 231264577 |
DEF 14C | Document | Definitive information statements Acc-no: 0001477932-23-005701 (34 Act) Size: 149 KB |
Aug-03-2023 | 231137590 |
PRE 14C | Document | Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001477932-23-005478 (34 Act) Size: 148 KB |
Jul-21-2023 | 231102319 |
8-K | Document | Current report filing Acc-no: 0001477932-23-005140 (34 Act) Size: 215 KB |
Jul-07-2023 | 231077739 |
8-K | Document | Current report filing Acc-no: 0001477932-22-008197 (34 Act) Size: 1134 KB |
Nov-07-2022 | 221365702 |
8-K | Document | Current report filing Acc-no: 0001477932-22-008165 (34 Act) Size: 152 KB |
Nov-04-2022 | 221362129 |
8-K | Document | Current report filing Acc-no: 0001477932-22-007249 (34 Act) Size: 91917 KB |
Sep-28-2022 | 221272702 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001477932-22-006497 (34 Act) Size: 22 KB |
Aug-29-2022 | 221211828 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-22-003079 (34 Act) Size: 4276 KB |
May-09-2022 | 22903097 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001425203-22-000009 (34 Act) Size: 18 KB |
Apr-14-2022 | 22826854 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001477932-22-001415 (34 Act) Size: 3980 KB |
Mar-15-2022 | 22741252 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001477932-22-001060 (34 Act) Size: 16 KB |
Feb-28-2022 | 22683391 |
8-K | Document | Current report filing Acc-no: 0001477932-22-001027 (34 Act) Size: 34 KB |
Feb-23-2022 | 22661487 |
8-K | Document | Current report filing Acc-no: 0001477932-22-000350 (34 Act) Size: 28 KB |
Jan-19-2022 | 22538421 |
8-K | Document | Current report filing Acc-no: 0001477932-22-000142 (34 Act) Size: 111493 KB |
Jan-07-2022 | 22516437 |
8-K | Document | Current report filing Acc-no: 0001425203-21-000024 (34 Act) Size: 22 KB |
Nov-24-2021 | 211448075 |
8-K | Document | Current report filing Acc-no: 0001477932-21-007491 (34 Act) Size: 3086 KB |
Oct-21-2021 | 211335088 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-21-007231 (34 Act) Size: 1267 KB |
Oct-13-2021 | 211321889 |
8-K | Document | Current report filing Acc-no: 0001477932-21-006544 (34 Act) Size: 3263 KB |
Sep-22-2021 | 211269398 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-21-004617 (34 Act) Size: 954 KB |
Jul-14-2021 | 211090084 |
Recent 20 filings. View all Instadose Pharma Corp. filings
Thanks I look forward to using the product to improve my skin tone
Huge help thank you for your help .. y'all make it so much easier
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by